The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Johnson & Johnson (NYSE: JNJ) closed at $155.35 up 0.50% from its previous closing price of $154.58. In other words, the price has increased by $0.50 from its previous closing price. On the day, 5.8 million shares were traded. JNJ stock price reached its highest trading level at $155.81 during the session, while it also had its lowest trading level at $153.8277.
Ratios:
For a deeper understanding of Johnson & Johnson’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.38. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.49.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $190.
Daiwa Securities Downgraded its Outperform to Neutral on July 23, 2024, whereas the target price for the stock was revised from $160 to $150.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 25 ’25 when Decker Robert J sold 6,999 shares for $165.88 per share. The transaction valued at 1,160,994 led to the insider holds 21,001 shares of the business.
Decker Robert J bought 6,999 shares of JNJ for $1,161,010 on Feb 25 ’25. On Feb 18 ’25, another insider, Schmid Timothy, who serves as the EVP, WW Chair, MedTech of the company, sold 403 shares for $156.15 each. As a result, the insider received 62,928 and left with 15,098 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JNJ now has a Market Capitalization of 374629662720 and an Enterprise Value of 387254484992. As of this moment, Johnson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.27, and their Forward P/E ratio for the next fiscal year is 14.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.19 while its Price-to-Book (P/B) ratio in mrq is 4.78. Its current Enterprise Value per Revenue stands at 4.335 whereas that against EBITDA is 12.942.
Stock Price History:
The Beta on a monthly basis for JNJ is 0.42, which has changed by 0.07441735 over the last 52 weeks, in comparison to a change of 0.097913146 over the same period for the S&P500. Over the past 52 weeks, JNJ has reached a high of $169.99, while it has fallen to a 52-week low of $140.68. The 50-Day Moving Average of the stock is -2.77%, while the 200-Day Moving Average is calculated to be -1.06%.
Shares Statistics:
For the past three months, JNJ has traded an average of 9.89M shares per day and 8576690 over the past ten days. A total of 2.41B shares are outstanding, with a floating share count of 2.41B. Insiders hold about 0.13% of the company’s shares, while institutions hold 72.99% stake in the company. Shares short for JNJ as of 1744675200 were 21018445 with a Short Ratio of 2.13, compared to 1741910400 on 24870261. Therefore, it implies a Short% of Shares Outstanding of 21018445 and a Short% of Float of 0.8699999999999999.
Dividends & Splits
According to the company, the forward annual dividend rate for JNJ is 4.96, from 4.96 in the trailing year. Against a Trailing Annual Dividend Yield of 0.032086946The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 84.80% for JNJ, which recently paid a dividend on 2025-02-18 with an ex-dividend date of 1748304000. Stock splits for the company last occurred on 2001-06-13 when the company split stock in a 2:1 ratio.
